Crossmark

The financial burden of vancomycin as an alternative to cefazolin for periprosthetic joint infection prophylaxis in total knee arthroplasty

Crossref DOI link: https://doi.org/10.1007/s00402-025-05879-9

Published Online: 2025-04-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Taylor IV, Walter L. https://orcid.org/0000-0002-2524-2968
Bergstein, Victoria

Weinblatt, Aaron

Long, William J.
License Information

Text and Data Mining valid from 2025-04-26

Version of Record valid from 2025-04-26
More Information

Article History

Received: 29 February 2024

Accepted: 10 April 2025

First Online: 26 April 2025